Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma
Clinical trial NCT00193544 · COMPLETED
Trial details
- NCT number
- NCT00193544
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2005-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.